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expensive as compared to colonoscopy or barium enema,
which may cost more than $1000.00. A guaiac-based test
was utilized costing approximately $0.81 per test.
METHOD: Patients in primary care were included in
routine preventive screening to include FOBTs. We eval-
uated 2021 FOBTs during FY1997.
RESULTS: $1637.01 was spent screening 2021 patients.
Four asymptomatic patients were detected to have colon
cancer as a result of this screening. One potential death
was prevented for every 505.25 patients screened.
CONCLUSION: In certain managed care patient popula-
tions, this may be an even more cost-effective approach
in colorectal screening.
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OBJECTIVE: In a cost analysis we compared the socio-
economic relevance of diagnostic screening to differenti-
ate type 2 diabetes mellitus patients with autoantibodies
from type 2 patients without screening. As the prevalence
of antibodies is—compared to older or younger pa-
tients—enhanced at the age of 30 to 45, this analysis fo-
cussed on this population of diabetes mellitus type 2 aged
30 to 45 years.
METHODS: In a decision tree analysis two groups of pa-
tients with diabetes mellitus one with and one without
screening were compared. Endpoints were diabetes associ-
ated late complications as myocardial infarction, stroke,
proliferative nephropathy, proliferative retinopathy, ma-
jor amputation caused by diabetic foot lesion. Costs of di-
abetes treatment are calculated over a period of 20 years
considering the high prevalence of late complications after
20 years duration of the disease. Costs of diabetes-associ-
ated late complications are analyzed over a period of 1
year. This analysis included both direct and indirect costs.
The model examined the costs from the perspective of the
payer (German sickness fund).
RESULTS: Over a period of 20 years total costs for diag-
nostic screening per patient amounts to DM 31,278 in-
cluding DM 7799 for direct and DM 23,479 for indirect
costs. The control group revealed total costs per patient of
DM 35,290 while direct costs amount to DM 10,984 and
indirect costs to DM 24,306. The projection of the total
population results in a cost saving potential of DM 2.6 bil-
lion after investment of DM 22.8 million for screening.
The model’s robustness was proved in sensitivity analyses.
CONCLUSION: Autoantibody screening of 30- to 45-
year-old diabetes mellitus patients reduces healthcare ex-
penditures as it decreases the prevalence of diabetes asso-
ciated late complications.
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Literature indicates that mammography screening is cost-
effective for detecting early-stage breast cancer in high-
risk populations compared to other medical interven-
tions. Mammographic interpretations are typically lim-
ited to single readers and studies do not necessarily ac-
count for the costs and effects associated with double
reading (mammography interpretation by two radiolo-
gists), when practiced. Compared to single reading (SR),
double reading (DR) has been shown to increase sensitiv-
ity although its effects on specificity and on costs and
outcomes are not clear.
OBJECTIVE: To review current literature regarding SR
and DR to assess 1) the value of DR and 2) the need for
cost-effectiveness analyses of DR versus SR.
METHODS: A review of clinical and economic literature
of SR and DR was performed.
RESULTS: A limited number of studies indicate that the
cost-effectiveness of DR depends upon the approach used.
Specifically, a difference emerges between consensus DR
(where two radiologists achieve agreement on interpreta-
tion) and independent DR. Overall, findings show that con-
sensus DR may be cost-effective compared to SR by increas-
ing sensitivity (by 5% to 15%) while decreasing the recall
rate (or increasing specificity) by 2% to 10%. In contrast,
independent DR appears to increase the recall rate at added
costs and therefore, may not be cost-effective.
CONCLUSION: An increase in sensitivity should be
weighed against the decrease in specificity associated with
DR. Additional cost-effectiveness analyses of DR (both in-
dependent and consensus) compared to SR should be con-
ducted to determine the overall value of DR and to guide
health policy decision-making. Cost-effectiveness analy-
ses could also be conducted to evaluate the value of new
computer-aided detection systems designed to improve
sensitivity without compromising specificity.
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OBJECTIVE: Mammography has been well established
as a cost-effective tool in breast cancer screening. How-
ever, low compliance has been a major obstacle to its suc-
cess. The current study is to compare the characteristics
of all programs that aimed at improving mammography
compliance and to examine their effectiveness on an ag-
gregate basis.
